We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DQ
1376
Daqo New Energy
DQ
$988M
| $54.7K | ﹤0.01% |
1,853
-52
| -3% | -$1.59K |
|
1377
Macy's
M
$6.26B
| $54.2K | ﹤0.01% |
+2,460
| New | +$50.4K |
|
1378
Pacira BioSciences
PCRX
$945M
| $54.1K | ﹤0.01% |
2,091
+354
| +20% | +$8.42K |
|
|
CIVI
1379
DELISTED
Civitas Resources
CIVI
| $54K | ﹤0.01% |
1,994
-153
| -7% | -$4.43K |
|
1380
Douglas Emmett
DEI
$1.95B
| $53.8K | ﹤0.01% |
4,894
+1,226
| +33% | +$15.4K |
|
1381
Diamondrock Hospitality Co
DRH
$2.5B
| $53.7K | ﹤0.01% |
5,990
+1,470
| +33% | +$12.5K |
|
1382
UroGen Pharma
URGN
$2.39B
| $53.3K | ﹤0.01% |
2,275
+486
| +27% | +$10.5K |
|
1383
Xencor
XNCR
$1.72B
| $53.1K | ﹤0.01% |
3,470
+713
| +26% | +$10.7K |
|
1384
Novavax
NVAX
$1.31B
| $53.1K | ﹤0.01% |
7,896
+1,617
| +26% | +$12.2K |
|
1385
Sana Biotechnology
SANA
$1.13B
| $52.7K | ﹤0.01% |
12,944
+2,943
| +29% | +$13.2K |
|
1386
Iovance Biotherapeutics
IOVA
$3.05B
| $52.7K | ﹤0.01% |
19,290
+5,301
| +38% | +$12.3K |
|
|
CRCL
1387
Circle Internet Group
CRCL
$18.1B
| $51.4K | ﹤0.01% |
648
-6,411
| -91% | -$663K |
|
1388
Lufax Holding
LU
$1.33B
| $51.3K | ﹤0.01% |
20,044
+1,218
| +6% | +$3.6K |
|
1389
Allison Transmission
ALSN
$10.2B
| $51.3K | ﹤0.01% |
+524
| New | +$45.9K |
|
1390
Erasca
ERAS
$6.5B
| $51.3K | ﹤0.01% |
13,787
+2,820
| +26% | +$7.93K |
|
1391
Global Net Lease
GNL
$1.9B
| $50.9K | ﹤0.01% |
5,913
+1,412
| +31% | +$11.3K |
|
1392
Vesta Real Estate
VTMX
$3.21B
| $50.8K | ﹤0.01% |
1,667
+91
| +6% | +$2.69K |
|
1393
Intellia Therapeutics
NTLA
$1.69B
| $50.6K | ﹤0.01% |
5,629
+1,479
| +36% | +$20.4K |
|
1394
RLX Technology
RLX
$2.47B
| $50K | ﹤0.01% |
21,458
+165
| +0.8% | +$395 |
|
1395
AbCellera Biologics
ABCL
$3.18B
| $49.7K | ﹤0.01% |
14,546
+2,993
| +26% | +$13.4K |
|
1396
Teck Resources
TECK
$32.4B
| $49.6K | ﹤0.01% |
1,036
-705
| -40% | -$30.5K |
|
1397
Monte Rosa Therapeutics
GLUE
$1.36B
| $49.6K | ﹤0.01% |
3,164
+776
| +32% | +$10.5K |
|
1398
Pampa Energía
PAM
$4.26B
| $48.3K | ﹤0.01% |
546
+30
| +6% | +$2.42K |
|
1399
Curtiss-Wright
CW
$26.7B
| $48K | ﹤0.01% |
+87
| New | +$48.5K |
|
1400
PubMatic
PUBM
$783M
| $47.5K | ﹤0.01% |
5,355
+91
| +2% | +$793 |
|
Similar funds
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.